Presently, there is consensus on an age-independent NT-proBNP for evaluation of CHF [13,14] and the percentage change of NT-proBNP after therapy is an important predictor of cardiovascular outcomes [21,22]. The gene discussed is NPPB; the disease is congestive heart failure.